Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Assessment of Tacrolimus Switch (Prograf to Envarsus)
NCT02882828Phase 4Completed
- Sponsor
- CHU de Limoges
- Start
- Oct 2016
- Primary completion
- Mar 2020
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplant rejection, Liver transplant rejection, sponsored by CHU de Limoges. Started Oct 2016; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejectionLiver transplant rejection
Beyond the preview
Go deeper on NCT02882828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02882828.